Caption Management, LLC Theravance Biopharma, Inc. Call Options Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$9.65 - $11.34 $96,500 - $113,400	-10,000 Reduced 4.76%	200,000 $2.24 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $1.76 Million - $2.15 Million	210,000 New	210,000 $2.13 Million
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $126,150 - $155,100	-15,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.33 - $12.96 $124,950 - $194,400	15,000 New	15,000 $143,000
Q3 2021 Nov 12, 2021	SELL	$6.77 - $14.41 $101,550 - $216,150	-15,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$14.52 - $22.46 $217,800 - $336,900	-15,000 Reduced 50.0%	15,000 $217,000
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $497,100 - $632,400	30,000 New	30,000 $611,000
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $446,700 - $604,800	-30,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $258,824 - $393,575	17,500 Added 140.0%	30,000 $443,000
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $223,000 - $390,125	12,500 New	12,500 $289,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.